Skip to main content

Bio-Techne starts seeking new CEO to replace Charles Kummeth when he retires

Bio-Techne CEO Charles Kummeth has started a two-year transition plan that will see him leave the top executive role, but maintain his position on the company’s board of directors, the manufacturer of biotechnology products said.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.